clofibrate has been researched along with alfibrate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, LT; Lam, HC; Li, SH; Tang, KT; Wang, JT | 1 |
| Hartmann, G; Stähelin, HB | 1 |
| Azanza Perea, JR; Honorato Pérez, J | 1 |
| Bruseghini, L; Dalmau, J; Vicens, B; Zapatero, J | 1 |
3 trial(s) available for clofibrate and alfibrate
| Article | Year |
|---|---|
The antilipemic effectiveness of aluminium clofibrate on hyperlipidemic patients with or without diabetes mellitus.
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Diabetes Complications; Double-Blind Method; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged | 1987 |
[Long-term effect of alufibrate in various types of hyperlipidaemia (author's transl)].
Topics: Adult; Aged; Aluminum; Cholesterol; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Drug Evaluation; Drug Tolerance; Female; Humans; Hyperlipidemias; Lipids; Lipoproteins; Male; Middle Aged; Phospholipids; Time Factors; Triglycerides | 1974 |
Plafibride tolerance trial at increasing doses in healthy volunteers.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Blood Cell Count; Blood Glucose; Clofibrate; Clofibric Acid; Double-Blind Method; Hemodynamics; Humans; Hypolipidemic Agents | 1981 |
1 other study(ies) available for clofibrate and alfibrate
| Article | Year |
|---|---|
[Single-blind study of the efficacy of pirozadil versus alufibrate in the treatment of primary hyperlipoproteinemias].
Topics: Cholesterol; Clofibrate; Clofibric Acid; Drug Evaluation; Female; Humans; Hyperlipoproteinemias; Lipoproteins; Male; Middle Aged; Platelet Aggregation; Pyridines; Random Allocation | 1982 |